Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Bio Rad Laboratories Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 06:15PM GMT
Release Date Price: $561.94 (+1.41%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. Here we go. Good afternoon, everybody. Luke Sergott from Barclays. I cover the life science tools and diagnostics space. And with me, I have the pleasure of introducing the Bio-Rad management team, Norman Schwartz, Ilan Daskal and Andy Last.

So if you guys want to give a quick kind of 2-minute update or a quick overview, that would be great, and then we can just dive right in.

Ilan Daskal
Bio-Rad Laboratories, Inc. - Executive VP & CFO

Sure, Luke. Probably you can dive in. I mean to your questions, we are obviously glad to participate in the Barclays conference. And let's start with the questions, and we can dive in.

Questions & Answers

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

There we go. All right. So as you guys think about how your guidance, what you guys issued at the beginning of the year, and then we're already a full quarter in. Give us an update on how you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot